Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.5492
Delayed Data
As of 4:00pm ET
 +0.0137 / +2.56%
Today’s Change
0.50
Today|||52-Week Range
0.96
-21.54%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization45.1K42.4K37.1K28.3K
 
 
 
 
 
 
Operating ExpensesGross Income-45.1K-42.4K-37.1K-28.3K
 
 
 
 
 
General Expenses16.1M6.1M7.9M13.2M
 
 
 
 
 
Other Operating Expenses0.00431.1K0.000.00
 
 
Research And Development12.0M3.4M3.3M7.0M
 
 
 
 
 
Total Operating Expenses16.1M6.6M8.0M13.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-16.1M-6.6M-8.0M-13.3M
 
 
 
 
 
Extraordinary Credit4.8M663.9K0.000.00
 
 
 
Extraordinary Charge0.00-332.1K-1.4M-5.2M
 
 
 
 
Other Expenses-101.6K0.00-204.2K-206.2K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.3M-6.2M-9.5M-18.5M
 
 
 
 
 
Net Income-11.3M-6.2M-9.5M-18.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS93.0M97.1M128.6M176.1M
 
 
 
 
 
Shares To Calculate EPS Diluted93.0M97.1M128.6M176.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.12-$0.06-$0.07-$0.11
 
 
 
 
 
EPS Diluted-$0.12-$0.06-$0.07-$0.11